BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38296306)

  • 1. Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.
    Zhang Y; Li Z; Huang Y; Zou B; Xu Y
    BMJ Open; 2024 Jan; 14(1):e073887. PubMed ID: 38296306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
    Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
    Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma.
    Mo C; Wu Y; Ma J; Xie L; Huang Y; Xu Y; Peng H; Chen Z; Zeng M; Mao R
    BMC Med Genomics; 2022 Apr; 15(1):81. PubMed ID: 35410253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of CKS2 and CD47 expression in patients with gastric cancer who underwent radical gastrectomy.
    Zhou Y; Zeng J; Zhou W; Wu K; Tian Z; Shen W
    Scand J Immunol; 2022 Oct; 96(4):e13198. PubMed ID: 35703112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
    Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
    Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z; Cheng H; Zhang Y; Zhou Y
    Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
    Feng F; Zhao Z; Cai X; Heng X; Ma X
    Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
    Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
    Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
    Li J; Huo X; Zhao F; Ren D; Ahmad R; Yuan X; Du F; Zhao J
    JAMA Netw Open; 2020 Oct; 3(10):e2020312. PubMed ID: 33048129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between LKB1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.
    Ren YH; Zhao FJ; Mo HY; Jia RR; Tang J; Zhao XH; Wei JL; Huo RR; Li QQ; You XM
    BMJ Open; 2019 Aug; 9(8):e027185. PubMed ID: 31383697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.
    Yu K; Ji Y; Liu M; Shen F; Xiong X; Gu L; Lu T; Ye Y; Feng S; He J
    Front Immunol; 2022; 13():881453. PubMed ID: 35663965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis.
    Ding P; Chen P; Ouyang J; Li Q; Li S
    Front Oncol; 2023; 13():1242231. PubMed ID: 37664060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.
    Wang JJ; Fang ZX; Ye HM; You P; Cai MJ; Duan HB; Wang F; Zhang ZY
    Dis Esophagus; 2013; 26(7):729-36. PubMed ID: 23301842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
    Kita Y; Nishizono Y; Okumura H; Uchikado Y; Sasaki K; Matsumoto M; Setoyama T; Tanoue K; Omoto I; Mori S; Owaki T; Ishigami S; Nakagawa H; Tanaka F; Mimori K; Mori M; Natsugoe S
    Oncol Rep; 2014 May; 31(5):1986-92. PubMed ID: 24604089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of tumour-infiltrating lymphocytes assessed by H&E-stained section in gastric cancer: a systematic review and meta-analysis.
    Tian C; Jing H; Wang C; Wang W; Cui Y; Chen J; Sha D
    BMJ Open; 2021 Jan; 11(1):e044163. PubMed ID: 33518526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis.
    Hu Y; Liu Z; Tang H
    Front Oncol; 2022; 12():977640. PubMed ID: 36263228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
    Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
    Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.